Navigation Links
Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohn's Disease in the European Union
Date:3/7/2013

OSAKA, Japan, March 7, 2013 /PRNewswire/ --

Takeda Pharmaceutical Company Limited ("Takeda") today announced that a Marketing Authorisation Application (MAA) has been submitted to The European Medicines Agency (EMA) for vedolizumab, an investigational, gut-selective humanized monoclonal antibody for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), the two most common types of inflammatory bowel disease (IBD). If approved, vedolizumab would be the first and only gut-selective biologic agent for UC and CD on the market.

"Ulcerative colitis and Crohn's disease are chronic debilitating diseases with important unmet medical needs, often affecting young people in the prime of their lives," said Asit Parikh , M.D., Ph.D., vice president, general medicine, Takeda. "We are encouraged by the findings of GEMINI, the vedolizumab Phase 3 clinical development program, which studied approximately 3,000 patients in nearly 40 countries, making it the largest IBD clinical trial program conducted to date."

Nearly four million people worldwide are affected by IBD, with UC affecting more than 500,000 people and CD affecting approximately 230,000 people in the EU.Crohn's disease and ulcerative colitis are chronic diseases that cause inflammation of the lining of the digestive tract. Inflammation caused by CD can involve varying areas of the digestive tract, while UC impacts the colon only.CD and UC can be both painful and debilitating, which may sometimes lead to serious complications and can significantly impact the quality of life for patients.

The MAA submission was supported by Phase 3 clinical studies, GEMINI I, GEMINI II, GEMINI III and GEMINI LTS (Long-term Safety), which are part of the GEMINI Studies™, a four-study clinical research program to investigate the efficacy and safety of vedolizumab on clinical response and remission
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
2. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
3. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
4. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
5. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
6. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
7. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
8. Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
9. Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102
10. Bayer Submits New Drug Application for Riociguat for the Treatment of Pulmonary Arterial Hypertension and Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
11. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014  MiMedx Group, Inc.  ... processor and marketer of patent-protected regenerative biomaterials and ... it has filed its initial Investigational New Drug ... ("FDA").   The IND submission, which ... Company,s initial submission for certain indications of its ...
(Date:7/23/2014)... , July 23, 2014 ... of the "Prepackaged Medical Kits and Trays ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... markets for Prepackaged Medical Kits and Trays in ... Custom Trays, Ophthalmic Custom Trays, Custom Basin Kits, ...
(Date:7/23/2014)... , July 23, 2014 Sinovac Biotech Ltd. (NASDAQ: ... in China , announced today that it ... and Prevention ("Beijing CDC") to be a supplier of the ... for 2014. The Beijing CDC plans ... seasonal flu vaccine this year from four domestic vaccine manufacturers ...
Breaking Medicine Technology:MiMedx Files Its Initial Investigational New Drug Application 2MiMedx Files Its Initial Investigational New Drug Application 3Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report 2Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu 2
... Feb. 16, 2011 New Mexico ... ), a developer of medical IT services and solutions that ... today the company will begin providing second opinion teleradiology interpretation ... "There is a solid market for patients and their families ...
... Fla., Feb. 16, 2011 One of America,s two largest ... pharmacy counters in nearly 3,000 stores.   To ... giving away through March 4 thousands of its bullet-shaped nasal ... bacteria.  Visit www.germbullet.com . "If you are ...
Cached Medicine Technology:New Mexico Software Initiates Medical Second Opinion Service via Telemedicine for Remote Consultation Review 2New Mexico Software Initiates Medical Second Opinion Service via Telemedicine for Remote Consultation Review 3Which Pharmacy Chain Offers GermBullet® Inhaler to Fight Exposure to Cold and Flu Viruses and Bacteria? 2
(Date:7/23/2014)... shown that some high-profile athletes who suffered repeated blows ... clumps in their brains. Those clumps suggest the athletes ... scientists are working on tests that might be able ... an article in Chemical & Engineering News (C&EN) ... Society. , In the article, Lauren Wolf, a senior ...
(Date:7/23/2014)... together for the first time to call for better ... worldwide suffering from the condition. , Psoriatic arthritis (PsA) ... damage if left untreated. , PsA tends to affect ... red, scaly rash, and affects approximately two per cent ... in five go on to develop PsA usually ...
(Date:7/23/2014)... Louis (PRWEB) July 23, 2014 Five years ... its doors there were few options for babies diagnosed with ... delivery, or travel across the country for innovative fetal therapies. ... Fetal Care Institute to care for their babies in the ... surgeries and interventions. , “A number of the babies ...
(Date:7/23/2014)... models of human oral cancer treated with an agent ... surrounding tissues, researchers from the School of Dentistry and ... Science Center at San Antonio found. The Health Science ... study, which is described in the journal Oral ... , Oral squamous cell carcinoma is the eighth most ...
(Date:7/23/2014)... July 23, 2014 SpaRoom® ... SpaRoom’s top product and premier diffuser, is now available ... and an improved motor for maximum quality. The new ... now available on SpaRoom.com for $60 along with the ... ultrasonic pulsations to create a long-lasting, tranquil mist. Add ...
Breaking Medicine News(10 mins):Health News:Psoriatic arthritis patients need better screening, warns panel of experts 2Health News:St. Louis Fetal Care Institute Marks Five Years of Life Changing Care and Fetal Surgery 2Health News:Anti-pain agent shrinks oral cancers, leaves healthy tissues alone 2Health News:SpaRoom® Unveils New Sleek Color, Improved AromaMist™ 2
... to The Diabetes Research Institute of Miami on ... behalf of the motorcycle franchisee, ... check to The Diabetes Research Institute of Miami in honor ... the,leading voluntary insurer announced the motorcycle franchisee as its,100,000th Online ...
... epilepsy and depression, researchers say , , FRIDAY, ... deep brain stimulation sensor that can monitor levels ... Clinic researchers and colleagues. , The wireless instantaneous ... the brain to provide real-time measurement of chemicals ...
... Local Patients May Be at,Risk, PHILADELPHIA, Sept. 12 ... blood supply alert for New Jersey and,southeastern Pennsylvania., ... critical need for Type O,blood. Brigid O,Neill-LaGier, Chief Executive ... the community to donate blood. "The blood,supply is a ...
... reports a hiring trend over the past four months within High-Tech ... is has become a “recruiters” market causing both parties to change ... ... 2008 -- Lucas Group, an executive search firm, today reports a ...
... yearn to wear the sheer, body-hugging fashions available today, we ... dreaded back fat rolls and lumps. A study published in ... the official medical journal of the American Society of Plastic ... these unsightly bumps and bulges while hiding the scar under ...
... ATSI ), manufacturer and marketer of state-of-the-art ... unprecedented number,of scientific presentations and symposia will focus ... for Cardio-Thoracic Surgeons (EACTS),meeting. The EACTS is a ... and is being held in Lisbon, Portugal from ...
Cached Medicine News:Health News:Aflac Celebrates With Peterson's Harley Davidson of Miami as 100,000th Online Billing Customer 2Health News:American Red Cross Issues Local Blood Supply Alert 2Health News:American Red Cross Issues Local Blood Supply Alert 3Health News:Lucas Group Reports Hiring Trend in High-Tech Medical Device 2Health News:Say 'goodbye' to back fat rolls 2Health News:ATS Medical Products Featured Prominently in Scientific Presentations at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting 2Health News:ATS Medical Products Featured Prominently in Scientific Presentations at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting 3Health News:ATS Medical Products Featured Prominently in Scientific Presentations at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting 4
... Forma 1400 Series ... specifically to revolutionize working ... cabinet. The most comfortable, ... Class II cabinet on ...
... The Premier 12 Holter Analysis Kit incorporates ... Dispersion with other powerful DMS Holter analysis ... TWA analysis possible in less than 10 ... TWA, for visual verification and validation. The ...
... Designed for ease of use and patient ... smooth edges for comfort and is available ... to a perfect fit. For hard to ... trach collar to your specifications. Don't just ...
... more comfortable, and you will too., ... and to avoid the knotty problems associated ... ties, consider the Dale® Tracheostomy Tube Holder. ... narrow fastener tabs of the Dale® Tracheostomy ...
Medicine Products: